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The Ami-AliA/AliB oligopeptide permease is an ATP-binding cassette transporter which is found in Strep-
tococcus pneumoniae and which is involved in nutrient uptake. We investigated the role of the three paralogous
oligopeptide-binding lipoproteins AmiA, AliA, and AliB by using murine models of pneumococcal colonization
and invasive disease. A series of mutants lacking aliA, aliB, and amiA either alone or in combination as double
or triple mutations were used. Inoculation of the nasopharynx with a mixture of the obl (oligopeptide-binding
lipoprotein-negative) triple-mutant and wild-type (D39) bacteria resulted in significantly smaller numbers of
obl bacteria colonizing the nasopharynx. The use of a mixture of individual mutants and wild-type pneumococci
revealed that AmiA, AliA, and AliB were all required for successful colonization of the nasopharynx. The obl
mutant was more attenuated than the aliB mutant but not the aliA or amiA mutant. Therefore, there is some
redundancy in the Ami-AliA/AliB complex in terms of nasopharyngeal colonization, with AliA and AmiA being
able to compensate for the removal of AliB. Animals with invasive disease caused by these mutants had survival
times, bacterial loads, and inflammatory cytokine production levels similar to those of animals infected with
wild-type pneumococci. Our results show that although the Ami-AliA/AliB complex is not required for virulence
during pneumococcal pneumonia, it does play a role in colonization of the nasopharynx.
Streptococcus pneumoniae remains a human pathogen of sig-
nificant importance despite the availability of adequate antibi-
otics and the current polysaccharide conjugate vaccine. The
worldwide increase in pneumococcal drug resistance and the
limited vaccine coverage of pneumococcal serotypes highlight
the need for the identification of pneumococcal proteins for
use as vaccine candidates.
The use of genome-based technologies allows the large-scale
detection of surface-expressed pneumococcal proteins that
have homology to virulence factors from other microbes.
These proteins may be used as new drug targets or may be
included in vaccine preparations. Recent studies highlighted
the importance of ATP-binding cassette (ABC) transporters in
the virulence of S. pneumoniae. Mutations in pneumococcal
ABC transporters result in the attenuation of pneumococcal
virulence in models of both pneumonia and bacteremia (11,
13).
The Ami-AliA/AliB oligopeptide permease was the first
ABC permease identified in a gram-positive bacterium (3).
This permease comprises three oligopeptide-binding lipopro-
teins, called AmiA (The Institute for Genomic Research des-
ignation SP1891), AliA (SP0366), and AliB (SP1527); the lat-
ter two are paralogues of AmiA (2), two transmembrane
proteins, AmiC (SP1890) and AmiD (SP1889), and two
ATPases, the ABC proteins AmiE (SP1888) and AmiF
(SP1887). The genes encoding AmiA and AmiC to AmiF are
all part of a single operon (3), whereas aliA and aliB are
separated on the pneumococcal genome.
The Ami-AliA/AliB oligopeptide permease is involved in
the uptake of nutrients from the environment in order to
overcome auxotrophy for various amino acids (6). Ami-AliA/
AliB may also act as an environmental signal allowing the
organism to adapt accordingly. Mutations in either amiA or
aliA have been suggested to decrease adherence to pulmonary
epithelial cells in vitro (7) due to reduced binding to the
GalNAc--1-4Gal glycoconjugate receptor on resting lung ep-
ithelial or vascular endothelial cells. It has also been proposed
that Ami-AliA/AliB may be involved in triggering competence,
since the cell-density-dependent control of competence was
altered in an obl mutant (6). Little is known about the effects
of Ami-AliA/AliB in vivo.
We have constructed a series of mutations in aliA, aliB, and
amiA either alone or in combination as double or triple mu-
tations (2). Using a well-characterized murine model of pneu-
mococcal infection (9), we have now investigated the relevance
of these genes in colonization and invasive disease.
MATERIALS AND METHODS
Bacteria. Serotype 2 D39 pneumococci were used as the parental strain for the
production of mutants and as the wild-type strain for infection. Construction of
the individual, double, and triple ami-aliA/aliB mutants was described previously
(2). Bacteria were cultured on blood agar base number 2 (Oxoid, Basingstoke,
United Kingdom) plus 5% (vol/vol) defibrinated horse blood (E&O Laborato-
ries, Bonnybridge, United Kingdom), in brain heart infusion broth (Oxoid; for
invasive disease studies), or in Todd-Hewitt broth plus 0.5% yeast extract (Ox-
oid; for colonization studies). Strain validation was based on optochin sensitivity
(Difco, Detroit, Mich.) and the Quellung reaction. During competitive coloni-
zation studies, amiA mutants were selected on 10 g of tetracycline/ml, aliB
mutants were selected on 2 g of chloramphenicol/ml, and both aliA and amiA
* Corresponding author. Mailing address: Division of Infection and
Immunity, Joseph Black Building, University of Glasgow, University
Ave., Glasgow G12 8QQ, United Kingdom. Phone: 44 141 330 3749.
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aliA aliB (obl [oligopeptide-binding lipoprotein-negative]) mutants were selected
on 1 g of erythromycin/ml. The rpsL gene, encoding a streptomycin-resistant
mutant of ribosomal protein S12, was used to transform D39 for competitive
colonization studies. Streptomycin-resistant D39 transformants were selected in
Todd-Hewitt broth plus 0.5% yeast extract and 100 g of streptomycin/ml, and
a single transformant clone was used in our animal experiments.
In order to maintain virulence, bacteria were animal passaged as previously
described (1) prior to use for infection.
Infection of mice. Eight- to 15-week-old female MF1 mice (Harlan Olac,
Bicester, United Kingdom) were used in all studies. To study invasive disease,
mice were lightly anesthetized with 1.5% (vol/vol) halothane, and 106 CFU of
D39 were introduced intranasally in a 50-l volume of phosphate-buffered saline.
For nasopharyngeal colonization assays, mice were anesthetized as described
above and inoculated intranasally with 2.5  105 CFU of each bacterial strain
either alone or in combination in a 10-l final volume. The combinations of
bacterial strains were D39 and obl or D39, amiA, aliA, and aliB.
Signs of disease were closely monitored until the animals were deemed mor-
ibund (10), when they were humanely sacrificed. Mice displaying no signs of
illness by 336 h were considered to have survived the infection. All experiments
were carried out in accordance with the UK Animals Scientific Procedures Act
of 1986.
Bacteriologic sample collection and processing. At predetermined times fol-
lowing infection, mice were sacrificed and blood samples were removed by
cardiac puncture. The nasopharynx was washed by using a modification of the
method of Wu et al. (15). The trachea was exposed and clamped, and 2 ml of
sterile phosphate-buffered saline was passed through the nasopharynx via a
16-gauge nonpyrogenic Angiocath (F. Baker Scientific, Runcorn, United King-
dom). Bronchoalveolar lavage and lung tissue sampling were carried out as
previously described (10).
Bacterial loads were determined by plating 10-fold dilutions on blood agar
plates plus 5% (vol/vol) defibrinated horse blood.
Cytokine assay sample collection and processing. Bronchoalveolar lavage fluid
(BALF) and lung tissue samples were snap-frozen on collection and processed by
the method of van der Poll et al. (14). Both BALF and lung tissue homogenates
were stored at80°C prior to use. Serum was prepared from blood samples after
30 min at room temperature by centrifugation at 3,800  g. Serum was stored at
80°C until use.
Tumor necrosis factor (TNF) activity was measured by using an L929 cytotox-
icity bioassay as previously described (10) with methylthiotetrazole to measure
cell viability. Interleukin-6 (IL-6) levels were measured by using an enzyme-
linked immunosorbent assay with commercially available antibodies (10).
Statistics. Survival times, expressed as medians, were compared by using
Mann-Whitney U analysis. Bacteriologic assay results were expressed as means
and standard errors of the means (SEMs). Results from bacteriologic time
course experiments were compared by using one-way analysis of variance with
Scheffe’s post hoc test. Bacteriologic assay results below the detection limits of
the viable count assays (log 1.92 units per ml of blood and log 0.92 unit per ml
of lung or nasopharyngeal samples) were ascribed values just below the detection
limits (log 1.91 and 0.91, respectively). Comparisons of bacterial loads between
bacterial strains were carried out by using multiple unpaired Student’s t tests with
Bonferroni correction.
In in vitro and in vivo competition studies with D39 and obl bacteria, the data
were mathematically corrected to account for the higher obl count in the initial
inoculum.
TNF and IL-6 levels, expressed as medians (minimum-maximum), were com-
pared by Mann-Whitney U analysis with Bonferroni correction for multiple
analyses.
Statistical analyses were carried out with StatView 4.1 (Abacus Concepts,
Berkeley, Calif.). A P value of0.05 was considered statistically significant for all
analyses.
RESULTS
obl bacteria are less able to colonize the nasopharynx than
D39 bacteria. In order to compare the abilities of the obl
mutant and D39 to colonize the nasopharynx, we carried out
competition infections in which the bacterial strains were in-
oculated together (Fig. 1).
Immediately following intranasal inoculation of 2.5  105
CFU of each strain, equal numbers of both obl and D39 bac-
teria were recovered from the nasopharynx (104 CFU/ml). The
viability of D39 was not altered significantly from the 0-h value
during the experiment. At 1 week after inoculation, D39 was
found to have colonized the nasopharynx at ca. 104 CFU/ml. In
parallel, the numbers of obl bacteria recovered at 24 and 48 h
were significantly lower than the number recovered at 0 h (P
0.05 and P  0.01, respectively). In addition, at 6 h, the viable
counts of obl bacteria within the nasopharynx were significantly
lower than those of D39 bacteria (P 0.05), and the reduction
from 12 h on was even more significant (P  0.01).
An experiment then was carried out with D39 or obl bacteria
administered intranasally to separate mice in order to investi-
gate whether the reduced colonization of obl bacteria (Fig. 1)
was due to the inability of obl bacteria to colonize or rather to
the failure of obl bacteria to compete in the presence of D39
bacteria. Even when obl bacteria were given alone, their via-
bility within the nasopharynx at 48 h (101 CFU/ml) (Fig. 2) was
significantly lower than that of D39 bacteria given alone (more
than 103 CFU/ml). Bacterial loads recovered for each bacterial
strain given alone (Fig. 2) were similar to those recovered for
the strains given in combination (Fig. 1).
The amiA, aliA, and aliB genes are all involved in nasopha-
ryngeal colonization. In order to identify which of the oli-
gopeptide-binding lipoproteins were required for the ability to
colonize the nasopharynx, a mixed culture of 2.5  105 CFU
each of D39 and the amiA, aliA, and aliB single mutants was
used to inoculate mice. Similar numbers of the individual bac-
terial strains were recovered immediately (Fig. 3). By 48 h,
significantly fewer amiA, aliA, and aliB pneumococci than D39
pneumococci were recovered (P  0.01, P  0.05, and P 
0.01, respectively). The numbers of amiA and aliA mutants
recovered were also significantly lower than the numbers of the
aliB mutant recovered.
Of note is the fact that none of the animals used in the
colonization studies showed signs of invasive disease. Immedi-
ately following inoculation of either D39 or obl bacteria only,
100 CFU could be recovered from the total lung samples. Lung
homogenates and blood samples taken at 48 h revealed no
FIG. 1. Mean and SEM viability of obl and D39 bacteria within the
nasopharynx following inoculation of a mixture of 2.5  105 CFU of
each strain into each of five mice. The broken line represents the
detection limit of the assay. A plus sign indicates a P value of 0.05
and an asterisk indicates a P value of 0.01 in a comparison of the
results for the two strains.
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viable pneumococci, proving that the model used represents
purely nasopharyngeal colonization.
Invasive disease caused by Ami-AliA/AliB mutants and that
caused by D39 result in similar survival times. Having estab-
lished that the Ami-AliA/AliB oligopeptide-binding lipopro-
teins play a role in nasopharyngeal colonization, we next in-
vestigated their role in invasive disease.
Intranasal infection with 106 CFU of any of the bacteria
resulted in clinical signs of illness at about 24 h. Initially, a mild
hunched stance was noted, followed by progression through
piloerection and lethargy. The median survival time of mice
infected with D39, amiA, aliA aliB, aliB amiA, aliA amiA, or obl
bacteria was 34 h, while mice infected with either aliA or aliB
bacteria survived to 46.5 h (Table 1). There were no significant
differences in the survival times of mice infected with any of
the amiA, aliA, and aliB single mutants and mice infected with
D39.
As intranasal infection with aliA, aliB, or amiA single mu-
tants or with aliA aliB, aliB amiA, or aliA amiA double mutants
did not significantly alter mouse survival times, the remaining
experiments were carried out only with obl bacteria.
Comparable levels of obl and D39 bacteria are recovered
within the nasopharynges, lung airways, and lung tissues dur-
ing pneumococcal pneumonia. Although intranasal infection
with the ami-aliA/aliB mutants did not result in significantly
different survival times, it was possible that there would be
differences in nasopharyngeal, lung, or blood bacteriologic as-
say results following infection. We therefore carried out basic
bacteriologic assays with D39 and obl bacteria separately.
Immediately following intranasal infection with either obl or
D39 bacteria, ca. 104 CFU/ml were recovered from the naso-
pharynx (Fig. 4A). The level of each strain then declined so
that by 24 h, 103 CFU/ml were recovered for each strain; this
level was significantly lower than that recovered at 0 h for both
groups (P  0.01).
Similar numbers of viable pneumococci were detected in the
lung airways of mice following infection with either obl or D39
bacteria (Fig. 4B). Between 103 and 104 CFU/ml of lung ho-
mogenate were found directly following infection with either
obl or D39 bacteria (Fig. 4C). The numbers of obl bacteria
increased during the experiment so that there were signifi-
cantly more at 24 h than at 0 h (P  0.01). The greater
variation in the D39 group prevented detection of statistical
significance.
At no time were there significant differences in bacterial
loads between mice infected with obl bacteria and those in-
fected with D39 bacteria.
Bacteremia develops with similar kinetics following intra-
nasal inoculation of obl bacteria and of D39 bacteria. The
development of systemic disease following intranasal inocula-
tion of either D39 or obl bacteria was investigated. Bacteremia
was first detected in mice infected intranasally with 106 CFU of
obl bacteria at 6 h postchallenge (Table 1). At this time, only
one of five mice was bacteremic. No mice infected with D39
were bacteremic until 12 h postchallenge. At this time, three of
FIG. 2. Mean and SEM viability of obl and D39 bacteria within the
nasopharynx following inoculation of 2.5 105 CFU of each strain into
each of five mice. The broken line represents the detection limit of the
assay. An asterisk indicates a P value of 0.01 in a comparison of the
results for the two strains.
FIG. 3. Mean and SEM bacterial load within the nasopharynx of
MF1 mice following inoculation of a mixture of 2.5 105 CFU each of
D39, amiA, aliA, and aliB bacteria into each of five mice. The broken
line represents the detection limit of the assay. A plus sign indicates a
P value of 0.05 and an asterisk indicates a P value of 0.01 in a
comparison of the results for the mutant strains and strain D39.
TABLE 1. Survival times and levels of bacteremia in mice
infected intranasally
Bacterial strain
Survival
time
(h)a
Mean  SEM log CFU/ml at the following h
postchallengeb:
0 6 12 24
D39 34 NF NF 3.20 0.70 5.76  1.02
aliA 46.5
aliB 46.5
amiA 34
aliA aliB 34
aliB amiA 34
aliA amiA 34
obl 34 NF 2.01 0.98 4.21  0.62 4.66  0.87
a Median survival times of 5 or 10 mice intranasally infected with 106 CFU of
D39 or various mutants.
b Levels of bacteremia following intranasal infection of five mice with either
D39 or the obl mutant were similar. NF, none found.
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five mice infected with D39 were bacteremic, while four of five
mice infected with obl bacteria had positive blood cultures.
Pneumococcal viable counts in the bloodstream continued to
increase in both groups of mice until the end of the experi-
ment. Significantly higher levels of pneumococci were recov-
ered from the bloodstream of mice infected with D39 and obl
bacteria at 24 h than at 0 h (P  0.01 and P  0.05, respec-
tively).
Similar levels of proinflammatory cytokines are produced
within the lung airways of mice infected with obl bacteria and
with D39 bacteria. To investigate whether the lack of expres-
sion of Ami-AliA/AliB affected proinflammatory cytokine ex-
pression, TNF activity and IL-6 levels in BALF from mice
infected intranasally with either D39 or obl were measured.
TNF activity increased transiently in BALF from mice in-
fected with either bacterial strain, with levels at 6 and 12 h
being significantly higher than those at 0 h (P 0.01) (data not
shown). By 24 h, levels were no longer significantly different
from the baseline.
IL-6 production within the lung airways increased gradually
following infection with either D39 or obl bacteria (data not
shown). Levels in both groups were higher at 24 h than at 0 h
(P  0.05).
At no time were there significant differences in TNF activity
or IL-6 levels between mice infected with D39 bacteria and
those infected with obl bacteria.
DISCUSSION
By using pneumococcal strains with targeted mutations in
the Ami-AliA/AliB permease, we have investigated the role of
this system in colonization and invasive disease.
Mutation of aliA, aliB, or amiA, either alone or in combina-
tion as double or triple mutants, does not significantly alter
survival times of mice following intranasal infection with 106
CFU in a 50-l volume (Table 1).
This lack of effect in invasive disease was also observed when
pneumococcal viability was measured. Similar bacterial loads
were recovered from the nasopharynges, lung airways, lung
tissues, and bloodstreams of mice infected with either D39 or
the obl mutant (Fig. 4).
Blue et al. previously found that in vivo proinflammatory
cytokine production can still be altered by mutations in S.
pneumoniae that do not alter bacterial loads (5). This was not
the case for obl bacteria. Both TNF activity and IL-6 levels
increased with typical kinetics and to similar extents during
invasive disease due to either wild-type or mutant bacteria.
Therefore, the Ami-AliA/AliB oligopeptide permease does
not appear to affect the virulence of serotype 2 S. pneumoniae
D39 in our model of bacteremic pneumonia. Previously, mu-
tations in aliB or amiA (as well as in amiC and amiD) were
found to result in attenuation in two separate models of pneu-
mococcal infection (8, 11). These studies identified aliB and
amiA via high-throughput screening (signature-tagged mu-
tagenesis) and, as Lau et al. (11) stated, this method of mu-
tagenesis may also result in unrelated changes elsewhere on
the genome. Alternatively, these differences may be attributed
to the use of different pneumococcal strains, since it has been
shown that the effect of a mutation depends on the strain of S.
pneumoniae used (4).
In contrast to our results for invasive disease, our results for
nasopharyngeal colonization do agree with those of another
signature-tagged mutagenesis screen that identified amiA (as
well as amiC and amiD) as being required for lung infection
(8). In our study, the coadministration of obl and D39 bacteria
to mice revealed that pneumococci deficient in amiA, aliA, and
aliB were less able to survive and colonize the nasopharynx
than were D39 pneumococci (Fig. 1). The same phenotype was
seen when the bacteria were administered separately (Fig. 2).
Therefore, by infecting mice with mixtures of mutant and
wild-type bacteria, we were able to study the effects of the
mutations but to use significantly fewer animals; the results
were similar to those obtained with individual infections. This
method allowed us to investigate the contribution of each of
the individual mutations in obl bacteria. The results revealed
that aliA, aliB, and amiA all play a role in nasopharyngeal
colonization. Depletion of any of the three encoded oligopep-
tide-binding lipoproteins resulted in pneumococci that were
less able to colonize the nasopharynx (Fig. 3). The aliA and
amiA genes appeared to play the most important role; a defi-
ciency in aliB had a less significant effect. It was previously
shown that AliB is the most important component of Ami-
FIG. 4. Mean and SEM bacterial loads within the nasopharynges (A), lung airways (B), and lung tissues (C) following intranasal inoculation
of 106 CFU of D39 or obl bacteria into each of five mice.
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AliA/AliB for oligopeptides containing arginine, whereas AliA
and AmiA are more vital for leucine-containing oligopeptides
(2). Our results may therefore reflect the nutrients available
within the nasopharynx. It remains a possibility that we would
have seen different results if we had investigated nasopharyn-
geal colonization with the individual mutants alone and over a
longer period of time.
That the levels of D39 in the nasopharynx did not remain at
ca. 104 CFU/ml during invasive disease studies (Fig. 4A), un-
like during specific nasopharynx colonization studies (Fig. 1),
might be explained by the bacterial inoculum and the host
response initiated.
It remains unclear whether the Ami-AliA/AliB oligopeptide-
binding lipoproteins are directly involved in binding to cells. It
is possible that some indirect effect of an ami-aliA/aliB defi-
ciency reduces adherence, perhaps by altering the expression
of distinct proteins involved in adhesion. Such an effect is
known for the regulation of the S. gordonii adhesin CshA by
the HppA oligopeptide-binding protein (12). An alternative
explanation for the lower bacterial loads of Ami-AliA/AliB
mutants within the nasopharynx may be that they are impaired
in a signaling mechanism that informs them of their environ-
ment so that they can adapt accordingly (6). Finally, they may
be unable to compete with the normal commensal flora for
nutrients. It would be interesting to repeat the amiA, aliA, and
aliB mutant colonization studies with other bacteria, for exam-
ple, Haemophilus influenzae, in this model.
In order to cause disease, the pneumococcus must first col-
onize the nasopharynx. It is from here that the organism is
spread to the lungs via aspiration. We have identified the
Ami-AliA/AliB oligopeptide-binding lipoproteins as novel
pneumococcal factors responsible for the initial colonization
step. It may be possible to target antibacterial agents against
the Ami-AliA/AliB proteins to prevent colonization and thus
subsequent infection.
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